Close Menu

Lennart Philipson, a virologist and microbiologist, died in June. In this week's PLoS Biology, David Baltimore writes that Philipson was "a force of nature" in the lab. "He is particularly noted for his work on the cellular receptors for viruses, on the assembly of adenoviruses, and on the control of adenovirus gene expression, but he made contributions to fields as disparate as serology and structure determination and everything in between," Balitmore says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.